Panosome
Pre-clinicalPanosome possesses a unique and powerful antibody generation platform (VAST) based on a highly immunogenic surface array of over ten million proteins with the option to convert this array into scalable nanoparticles spanning several orders of magnitude in size.
Founded
2017
Focus
AntibodiesBiologics
About
Panosome possesses a unique and powerful antibody generation platform (VAST) based on a highly immunogenic surface array of over ten million proteins with the option to convert this array into scalable nanoparticles spanning several orders of magnitude in size.
Company Info
TypePrivate
Founded2017
LocationMunich, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile